Cited 9 times in
TCF1+PD-1+ tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancer
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.